59 related articles for article (PubMed ID: 2605977)
1. Response to and concentration of interleukin-2 in patients with nasopharyngeal carcinoma.
Hsu MM; Hsu LW
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Aug; 22(3):181-5. PubMed ID: 2605977
[TBL] [Abstract][Full Text] [Related]
2. [A study of T-lymphocyte subsets, IL-2 production and IL-2 receptor expression in peripheral blood lymphocytes in patients with nasopharyngeal carcinoma].
Tan GL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(3):167-9, 188. PubMed ID: 8217300
[TBL] [Abstract][Full Text] [Related]
3. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin.
Hsu MM; Lo P
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721
[TBL] [Abstract][Full Text] [Related]
4. Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance.
Laytragoon-Lewin N; Porwit-MacDonald A; Mellstedt H; Lewin F
Anticancer Res; 2000; 20(2B):1093-100. PubMed ID: 10810402
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma.
Bao YX; Wong CK; Leung SF; Chan AT; Li PW; Wong EL; Leung PC; Fung KP; Yin YB; Lam CW
J Altern Complement Med; 2006 Oct; 12(8):771-6. PubMed ID: 17034283
[TBL] [Abstract][Full Text] [Related]
6. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
7. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
Hsu MM; Lin BL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative response to membrane extracts of nasopharyngeal carcinoma.
Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Kawamura A
Gan; 1980 Aug; 71(4):441-50. PubMed ID: 6253346
[TBL] [Abstract][Full Text] [Related]
9. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma.
Chow KC; Chiou SH; Ho SP; Tsai MH; Chen CL; Wang LS; Chi KH
Oncol Rep; 2003; 10(4):813-9. PubMed ID: 12792728
[TBL] [Abstract][Full Text] [Related]
10. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic response and interleukin 2 production in Crohn's disease.
Miura M; Hiwatashi N
J Clin Lab Immunol; 1987 Nov; 24(3):113-6. PubMed ID: 3501474
[TBL] [Abstract][Full Text] [Related]
12. Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapy.
Favrot M; Capdeville R; Combaret V; Zhou DC; Clapisson G; Banchereau J; Franks CR; Chouaib S; Blay JY; Philip T
Eur Cytokine Netw; 1990; 1(3):141-7. PubMed ID: 2129798
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma.
Farhat K; Hassen E; Gabbouj S; Bouaouina N; Chouchane L
Int J Immunogenet; 2008 Jun; 35(3):197-205. PubMed ID: 18312596
[TBL] [Abstract][Full Text] [Related]
14. TNF alpha enhancement of NK and LAK cell functions induced by high-dose IL-2 in human peripheral blood mononuclear cells from patients pretreated with alpha IFN + IL-2.
Favrot M; Combaret V; Blay JY; Capdeville R; Zhou DC; Clapisson G; Chouaib S; Franks CR; Philip T
Eur Cytokine Netw; 1990; 1(4):221-7. PubMed ID: 2104243
[TBL] [Abstract][Full Text] [Related]
15. [Correlation of pretreatment serum level of endostatin to posttreatment distant metastasis in patients with advanced nasopharyngeal carcinoma].
Zhao ZJ; Mo HY; Zhang CQ; Qi B; Li J; Hong MH; Mai HQ
Ai Zheng; 2007 Nov; 26(11):1243-7. PubMed ID: 17991326
[TBL] [Abstract][Full Text] [Related]
16. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells.
Huang YT; Sheen TS; Chen CL; Lu J; Chang Y; Chen JY; Tsai CH
Cancer Res; 1999 Apr; 59(7):1599-605. PubMed ID: 10197635
[TBL] [Abstract][Full Text] [Related]
17. Lymphocyte subsets and EB virus antibodies in nasopharyngeal carcinoma.
Lynn TC; Hsieh RP; Tu SM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 May; 18(2):70-8. PubMed ID: 2994964
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
20. Effect of interleukin 15 and interleukin 2 on anti-CD3-induced T-cell activation and apoptosis in children with common variable immunodeficiency.
Lin SJ; Chao HC; Chang KW; Yan DC
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):65-70. PubMed ID: 12877452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]